Igene Biotechnology, Inc.
IGNE
$0.00
$0.000.00%
OTC PK
| 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | 09/30/2009 | |
|---|---|---|---|---|---|
| Net Income | -2.37M | -1.63M | -1.39M | -140.80K | -1.12M |
| Total Depreciation and Amortization | 169.80K | 173.20K | 177.10K | 181.40K | 308.40K |
| Total Amortization of Deferred Charges | 10.30K | 10.30K | 10.30K | 10.30K | 239.60K |
| Total Other Non-Cash Items | -1.18M | 213.00K | -621.00K | -2.24M | -342.40K |
| Change in Net Operating Assets | 1.69M | 667.90K | 2.07M | 2.09M | 1.85M |
| Cash from Operations | -1.68M | -567.60K | 249.70K | -97.10K | 931.90K |
| Capital Expenditure | 16.60K | 16.60K | 31.20K | -171.80K | -171.10K |
| Sale of Property, Plant, and Equipment | 300.00 | 300.00 | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 17.00K | 17.00K | 31.20K | -171.80K | -171.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 12.90K | 1.70K | 57.70K | 76.10K | 9.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.65M | -548.80K | 338.70K | -192.80K | 770.30K |